Home›Signals›Dilution Risk Scores
⚠️

Dilution Risk Scores

Companies with high risk of share dilution

50 Active Signals
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 4.9 months cash DilutionScore: 98
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 4.9 months cash DilutionScore: 98
D
39/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 1.7 months cash DilutionScore: 98
D
36/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 4.9 months cash DilutionScore: 98
D
39/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 1.7 months cash DilutionScore: 98
D
36/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 4.9 months cash DilutionScore: 98
D
39/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 1.7 months cash DilutionScore: 98
D
36/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 4.9 months cash DilutionScore: 98
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 4.9 months cash DilutionScore: 98
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 4.9 months cash DilutionScore: 98
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 98/100 (CRITICAL), 4.9 months cash DilutionScore: 98
D
39/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 96/100 (CRITICAL), 1.7 months cash DilutionScore: 96
D
36/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 96/100 (CRITICAL), 1.7 months cash DilutionScore: 96
D
36/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 96/100 (CRITICAL), 1.7 months cash DilutionScore: 96
D
36/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 96/100 (CRITICAL), 1.7 months cash DilutionScore: 96
D
36/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 96/100 (CRITICAL), 1.7 months cash DilutionScore: 96
D
36/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 94/100 (CRITICAL), 11.2 months cash DilutionScore: 94
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 94/100 (CRITICAL), 11.2 months cash DilutionScore: 94
D
39/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 93/100 (CRITICAL), 1.7 months cash DilutionScore: 93
D
36/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 93/100 (CRITICAL), 1.7 months cash DilutionScore: 93
D
36/100
ARTLArtelo Biosciences, Inc.Biotech / Pharma
Dilution score: 93/100 (CRITICAL), 1.7 months cash DilutionScore: 93
D
36/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 92/100 (CRITICAL), 11.2 months cash DilutionScore: 92
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 92/100 (CRITICAL), 11.2 months cash DilutionScore: 92
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 92/100 (CRITICAL), 11.2 months cash DilutionScore: 92
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 92/100 (CRITICAL), 11.2 months cash DilutionScore: 92
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 92/100 (CRITICAL), 11.2 months cash DilutionScore: 92
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 92/100 (CRITICAL), 11.2 months cash DilutionScore: 92
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 92/100 (CRITICAL), 11.2 months cash DilutionScore: 92
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 92/100 (CRITICAL), 11.2 months cash DilutionScore: 92
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 92/100 (CRITICAL), 11.2 months cash DilutionScore: 92
D
39/100
ERNAErnexa Therapeutics Inc.Biotech / Pharma
Dilution score: 92/100 (CRITICAL), 11.2 months cash DilutionScore: 92
D
39/100
CLDICalidi Biotherapeutics, Inc.Biotech / Pharma
Dilution score: 91/100 (CRITICAL), 5.7 months cash DilutionScore: 91
D
37/100
CLDICalidi Biotherapeutics, Inc.Biotech / Pharma
Dilution score: 91/100 (CRITICAL), 5.7 months cash DilutionScore: 91
D
37/100
BNZIBanzai International, Inc.RNA Therapy
Dilution score: 89/100 (CRITICAL), 0.2 months cash DilutionScore: 89
F
35/100
BNZIBanzai International, Inc.RNA Therapy
Dilution score: 89/100 (CRITICAL), 0.2 months cash DilutionScore: 89
F
35/100
FBLGFibroBiologics, Inc.Biotech / Pharma
Dilution score: 89/100 (CRITICAL), 5.9 months cash DilutionScore: 89
F
33/100
FBLGFibroBiologics, Inc.Biotech / Pharma
Dilution score: 89/100 (CRITICAL), 5.9 months cash DilutionScore: 89
F
33/100
BNZIBanzai International, Inc.RNA Therapy
Dilution score: 89/100 (CRITICAL), 0.2 months cash DilutionScore: 89
F
35/100
FBLGFibroBiologics, Inc.Biotech / Pharma
Dilution score: 89/100 (CRITICAL), 5.9 months cash DilutionScore: 89
F
33/100
CLDICalidi Biotherapeutics, Inc.Biotech / Pharma
Dilution score: 89/100 (CRITICAL), 5.7 months cash DilutionScore: 89
D
37/100
BNZIBanzai International, Inc.RNA Therapy
Dilution score: 89/100 (CRITICAL), 0.2 months cash DilutionScore: 89
F
35/100
FBLGFibroBiologics, Inc.Biotech / Pharma
Dilution score: 89/100 (CRITICAL), 5.9 months cash DilutionScore: 89
F
33/100
CLDICalidi Biotherapeutics, Inc.Biotech / Pharma
Dilution score: 89/100 (CRITICAL), 5.7 months cash DilutionScore: 89
D
37/100
BNZIBanzai International, Inc.RNA Therapy
Dilution score: 89/100 (CRITICAL), 0.2 months cash DilutionScore: 89
F
35/100
FBLGFibroBiologics, Inc.Biotech / Pharma
Dilution score: 89/100 (CRITICAL), 5.9 months cash DilutionScore: 89
F
33/100
CLDICalidi Biotherapeutics, Inc.Biotech / Pharma
Dilution score: 89/100 (CRITICAL), 5.7 months cash DilutionScore: 89
D
37/100
BNZIBanzai International, Inc.RNA Therapy
Dilution score: 89/100 (CRITICAL), 0.2 months cash DilutionScore: 89
F
35/100
FBLGFibroBiologics, Inc.Biotech / Pharma
Dilution score: 89/100 (CRITICAL), 5.9 months cash DilutionScore: 89
F
33/100
CLDICalidi Biotherapeutics, Inc.Biotech / Pharma
Dilution score: 89/100 (CRITICAL), 5.7 months cash DilutionScore: 89
D
37/100
BNZIBanzai International, Inc.RNA Therapy
Dilution score: 89/100 (CRITICAL), 0.2 months cash DilutionScore: 89
F
35/100
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.